As previously explained, aberrant STAT3 activity drives the expression of genes that promote the cancer phenotype, including proliferation, resistance to apoptosis, metabolic changes, metastasis/angiogenesis, and immune system derangement [6,106]. This evidence concerns the gene STAT3 and cancer.